Long‐term outcomes of a phase II randomized controlled trial comparing intensity‐modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma

Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study

Cancer Cell International, 24 Jan 2022

Abstract Background To determine whether concurrent chemotherapy is necessary during locoregional radiotherapy (RT) after…